Perioperative Complication Clinical Trial
Official title:
Short Term Outcome of SGLT2 Inhibitors on Patients Who Undergo Cardiac Surgery in Perioperative Period
The expanded use of SGLT2 inhibitors motivates us to assess the role of SGLT2 inhibitors in perioperative period on patients who will undergo cardiac surgery in Assiut University.
With over 50 million cases of heart failure worldwide, heart failure is one of the most serious health issues facing humanity. Heart failure patients still have an extremely poor prognosis and quality of life, even with advancements in heart failure treatment. It continues to be the most common cause of hospitalization in elderly. A substantial number of theories have been proposed to explain the beneficial effects of SGLT2 inhibitors. These include blood pressure lowering, increasing diuresis/natriuresis, improving cardiac energy metabolism, preventing inflammation, weight loss, improving glucose control, inhibiting the sympathetic nervous system, preventing adverse cardiac remodeling, preventing ischemia/reperfusion injury, inhibiting the cardiac Na/H exchanger inhibiting SGLT1, reducing hyperuricemia, increasing autophagy and lysosomal degradation, decreasing epicardial fat mass, increasing erythropoietin (EPO) levels, increasing circulating provascular progenitor cells, decreasing oxidative stress; and improving vascular function. In addition to lowering blood sugar, several large trials also have demonstrated cardiovascular and renal benefits in patients with T2DM. Surprisingly, recent data also suggest that SGLT-2 inhibitors may improve cardiovascular and renal outcomes in patients without diabetes, leading to expanded indications for their use. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT04167410 -
Effect of Perioperative Glycemia Protocol on Glycemic Outcomes in Diabetic Patients Undergoing Abdominal Surgery
|
N/A | |
Terminated |
NCT04506372 -
Management of Angiotensin Inhibitors During the Perioperative Period
|
N/A | |
Completed |
NCT04006106 -
Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
|
||
Recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
N/A | |
Completed |
NCT06203171 -
Preoperative Evaluation on Perioperative Complications
|
||
Completed |
NCT04120324 -
Incidence of 30 Day Return to Hospital Following Same Day Discharge Total Hip Arthroplasty
|
||
Not yet recruiting |
NCT06279000 -
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
|
Phase 3 | |
Completed |
NCT02958293 -
Perioperative Morbidity in Elective Surgery Based on the Time of the Year
|
||
Recruiting |
NCT04120012 -
The Effect of Frailty to Perioperative Complications in the Elderly
|
||
Completed |
NCT04665349 -
Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments
|
N/A | |
Recruiting |
NCT04266574 -
BRAIN-targeted Goal-directed Therapy in High-risk Patients undeRgOing Major electIve SurgEry: the BRAIN-PROMISE Study
|
N/A | |
Recruiting |
NCT04256798 -
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
|
Phase 3 | |
Completed |
NCT04260334 -
Preoperative Care In Ovarian Cancer Patients
|
N/A | |
Recruiting |
NCT05533112 -
Binaural Beat Stimulation to Improve Patient Outcome After Surgery and Anesthesia
|
N/A | |
Completed |
NCT06097052 -
Hypotension Predictive Index Effect on Intraoperative Hypotension During Pancreatic Surgery.
|
||
Recruiting |
NCT06035627 -
The Effect of Inadvertent Perioperative Hypothermia on Surgical Site Infection in Laparoscopic Choleistectomy.
|
||
Recruiting |
NCT04347772 -
Effectiveness of Intensive Perioperative Nutrition Therapy Among Adults Undergoing Gastrointestinal & Oncology Surgery
|
N/A | |
Completed |
NCT03974321 -
Intraoperative Hypotension and Perioperative Myocardial Injury
|
||
Completed |
NCT04573738 -
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer
|
N/A |